Castuner
Submit a podcast

Targeted Talks

Targeted Oncology

Targeted Talks is a podcast series from Targeted Oncology featuring one-on-one conversations with leading oncologists about the issues shaping cancer care today. Each episode explores the real-world challenges clinicians face alongside discussions of emerging research across tumor types. Whether unpacking new data, translating conference highlights into clinical context, or addressing the practical realities of oncology practice, Targeted Talks delivers timely, actionable conversations designed for today's oncology professionals. For more visit: https://www.targetedonc.com/podcasts

Podcast website

Listen in your app

Episodes

99 episodes

  1. S8 Ep9: Dr Bazhenova on the Updated FDA Label for Taletrectinib in ROS1+ NSCLC 7:00
  2. S8 Ep8: Lung Cancer in Hispanic and Latinx Patients: Risk Factors, Biomarkers, and Clinical Trial Access 18:26
  3. S8 Ep7: Dr Jhaveri on the FDA Approval of Imlunestrant Plus Abemaciclib for ESR1-Mutated Breast Cancer 11:53
  4. S8 Ep6: Dr Herzberg on the Expanding Toolkit in KRAS-Mutant Non–Small Cell Lung Cancer 15:53
  5. S8 Ep5: ASTRO 2026 Preview: Dr Raj Singh on De-Escalation, Brain Metastases, and What's Next in Radiation Oncology 19:37
  6. S8 Ep4: Bringing CAR T and Bispecifics to the Community 18:13
  7. S8 Ep3: Rethinking HER2: A Pan-Cancer Look at IHC, ERBB2, and Tumor-Agnostic Testing 23:28
  8. S8 Ep2: Radiation Oncology's Financial Squeeze with Dr Ryan Funk 21:26
  9. S8 Ep1: Gynecologic Cancer Trends, Testing, and Treatment Advances Explained 16:00
  10. S7 Ep19: AI in Oncology: Managing Information Overload for Trainees and Patients 16:27
  11. S7 Ep18: Drowning in Data: How Oncologists Are Coping with Information Overload in the AI Era 21:20
  12. S7 Ep17: Navigating the 505(b)(2) Pathway: Operational, Clinical, and Economic Strategies for Oncology Practices 22:04
  13. S7 Ep16: ASCO 2026 Preview: Late-Breaking Abstracts Poised to Reshape the Treatment Landscape 11:09
  14. S7 Ep15: Pediatric Blood Cancers: Building Better Outcomes Through Bold Science 28:46
  15. S7 Ep14: Choosing Wisely in CLL: A Deep Dive Into Frontline Treatment 32:55
  16. S7 Ep13: Leveraging AI, Social Media, and Virtual Care in the Information Age 43:22
  17. S7 Ep12: Beyond Monotherapy: Mechanisms and Combination Strategies in NPM1-Mutant Acute Myeloid Leukemia 40:54
  18. S7 Ep11: Treating Together: Navigating Treatment Decisions in Relapsed NPM1-Mutant AML: Practical Insights for Clinical Care 41:07
  19. S7 Ep10: Beyond the Hospital Walls: Expanding Access to Complex Cancer Therapies 41:19
  20. S7 Ep9: Test First, Treat Second: ASCO's Updated Approach to Driver Mutation–Negative NSCLC 12:45
  21. S7 Ep8: Precision Hope: The New Frontier of AI-Driven Oncology 35:51
  22. S7 Ep7: Community Oncology at a Crossroads: Navigating Policy, Progress, and Practice 43:34
  23. S7 Ep6: Navigating the Future of CLL Care 17:01
  24. S7 Ep5: Supporting Community Oncologists in a GU Research Era with Dr. Park, Dr. Garmezy, and Dr. Bupathi 27:02
  25. S7 Ep4: Gut Health & Myeloma: How Bacteria May Predict Transplant Success With Pooja Phull, MD 7:05
  26. S7 Ep3: Experts Delve Into Organ Preservation for Genitourinary Cancers 26:10
  27. S7 Ep2: Navigating Modern Lung Cancer Treatment and Clinical Trial Access 22:33
  28. S7 Ep1: Advancing Prostate Cancer Treatment With Shared Decision-Making 24:47
  29. S6 Ep5: Predicting Palbociclib Outcomes in Breast Cancer Using Deep Learning 36:35
  30. S6 Ep4: BMT CTN 1902 in Myeloma: Key Findings With Garfall 14:48
  31. S6 Ep3: Exploring Innovations in Lymphoma Treatment With Russler-Germain 27:50
  32. S6 Ep2: Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia 8:13
  33. S6 Ep1: Juneja Explores AI’s Impact in Early Cancer Detection and Treatment 35:13
  34. S5 Ep20: How AI Is Revolutionizing Oncology in Diagnosis, Treatment, and Research 16:28
  35. S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander 27:56
  36. S5 Ep18: Turning Inspiration Into Innovation: Hazim’s Impact on Oncology 16:20
  37. S5 Ep17: Kaklamani's Insights on EMERALD Trial and Elacestrant in Advanced Breast Cancer 13:41
  38. S5 Ep16: Foran Goes Beyond the Basics of BPDCN 22:32
  39. S5 Ep15: Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates 30:43
  40. S5 Ep14: Breaking New Ground in Synovial Sarcoma: Choy on the FDA Approval of Afami-cel 16:05
  41. S5 Ep13: Cancer Research Across Continents: Fujiwara’s Path From Japan to the US 19:23
  42. S5 Ep12: Advancing Melanoma Treatment: Hamid on Lifileucel's Role 18:04
  43. S5 Ep11: Transforming Prostate Cancer Care Through Personalized Medicine 23:58
  44. S5 Ep10: Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM 20:11
  45. S5 Ep9: Unlocking the Potential of Technology in Community Oncology 25:49
  46. S5 Ep8: LaPelusa’s Journey in the Dynamic Field of GI Oncology 14:20
  47. S5 Ep7: The Future of Breast Cancer Care: Blackwood on Personalized Approaches 26:53
  48. S5 Ep6: Dizman’s Global Pursuit to Cancer Research and Understanding 19:05
  49. S5 Ep5: FDA Approval Marks Amivantamab's Milestone in EGFR+ NSCLC 22:32
  50. S5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC 19:03